mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.8 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.0098 |
0.9 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.9 |